Author

H. Steuber

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 1

Frequent Co-Authors

A. Kaghad· 1 shared A. Kamburov· 1 shared A. Lakner· 1 shared A. Li· 1 shared A. Montebaur· 1 shared A. O. Walter· 1 shared A. Schlicker· 1 shared A. Steffen· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

A. Kaghad

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Novel YAP1/TAZ pathway inhibitors identified through phenotypic screening with potent anti-tumor activity via blockade of GGTase-I / Rho-GTPase signaling

K. Graham, P. Lienau, B. Bader, S. Prechtl, J. Naujoks, R. Lesche, J. Weiske, J. Kuehnlenz, K. Brzezinka, L. Potze, F. Zanconato, B. Nicke, A. Montebaur, W. Bone, S. Golfier, , M. Lange

bioRxiv · Aug 30, 2023 · PreprintCancer Biology

Rational Design and Synthesis of Selective PRMT4 Inhibitors: a New Chemotype for Development of Cancer Therapeutics

M. Sutherland, A. Li, A. Kaghad, D. Panagopoulos, F. Li, M. Szewczyk, D. Smil, C. Scholten, L. Bouche, T. Stellfeld, C. Arrowsmith, D. Barsyte, M. Vedadi, I. V. Hartung, H. Steuber, , V. Santhakumar

This study designs and synthesizes a new class of selective PRMT4 inhibitors with improved selectivity over other PRMT family members.

bioRxiv · Nov 17, 2020Pharmacology & Toxicology